Want to join the conversation?
$AMGN said it launched 6 new products last year, 2 in the cardiovascular arena and 4 in cancer. The company stated these products are still in the early stages of their launch cycle globally. $AMGN remains excited about the long-term prospects of Repatha and looks forward to important clinical data set to emerge later in 2016 and early 2017.
$AAL is giving pay hikes to its employees but investors are sulking.
$APC stock tumbled more than 5.6% after last week's fatal home explosion in Firestone, Colorado prompted the company to close more than 3,000 wells for weeks.
Unicorn Frappuccino. The latest hit from $SBUX. Can't wait to see how this will affect its results.
At what point should $AMZN consider a stock split? $1000 per share seems pretty high.